129Xe MRI Cardiopulmonary

Recruiting Phase 2 Interventional Study
Interstitial Lung Disease Chronic Thromboembolic Pulmonary Hypertension Acute Pulmonary Embolism Anemia Polycythemia Dyspnea
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Diagnostic
Participants needed
125 (estimated)
Sponsor
Bastiaan Driehuys · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of this NIH-sponsored study is to characterize three biomarkers derived from 129Xe gas exchange MRI and to understand how they change in response to interventions.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for Healthy Volunteers: (Inclusion Criteria: Subjects must meet all of the following inclusion criteria to be eligible for enrollment into the trial) 1. Outpatients of either gender, age \> 18 2. Willing and able to give informed consent and adhere to visit/protocol (Consent mus…
Contacts

Bastiaan Driehuys, PhD

919-684-7786

bastiaan.driehuys@duke.edu

CONTACT